lentinan has been researched along with Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, M; Mushiake, H; Nukatsuka, M; Shimao, K; Tahara, H; Tsunoda, T | 1 |
| Hamuro, J; Kikuchi, T; Suzuki, M; Takatsuki, F | 1 |
| Guo, JW; Huang, XF; Li, JF | 1 |
3 other study(ies) available for lentinan and Lymphoma
| Article | Year |
|---|---|
Dendritic cells might be one of key factors for eliciting antitumor effect by chemoimmunotherapy in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Dendritic Cells; Drug Combinations; Fibrosarcoma; Immunotherapy, Adoptive; Lentinan; Lung Neoplasms; Lymphoma; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasms, Experimental; Oxonic Acid; Pyridines; Rats; Rats, Inbred Strains; Spleen; Survival Rate; T-Lymphocytes, Cytotoxic; Tegafur | 2005 |
Curative effects of combination therapy with lentinan and interleukin-2 against established murine tumors, and the role of CD8-positive T cells.
Topics: Animals; CD8 Antigens; Chemotherapy, Adjuvant; Female; Flow Cytometry; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Lentinan; Lymphocyte Depletion; Lymphoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Moloney murine leukemia virus; Sarcoma, Experimental; Specific Pathogen-Free Organisms; T-Lymphocytes, Cytotoxic | 1994 |
[Study on the enhancing effect of polyporus polysaccharide, mycobacterium polysaccharide and lentinan on lymphokine-activated killer cell activity in vitro].
Topics: Cytotoxicity, Immunologic; Drug Synergism; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Lentinan; Leukemia, Erythroblastic, Acute; Lymphoma; Mycobacterium; Polyporaceae; Polysaccharides; Polysaccharides, Bacterial; Recombinant Fusion Proteins; Tumor Cells, Cultured | 1996 |